EN
HI
Aspira Pathlab & Diagnostics Share price
ASPIRA
54.39
2.59 (5.00%)Last updated on 30 May, 2025 | 15:10 IST
BUYSELL
Today's High
54.39
Today's Low
51.55
52 Week Low
25.00
52 Week High
106.78
The current prices are delayed, login to your account for live prices
LoginAspira Pathlab & Diagnostics Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
3807.00
Market Cap
53.32 CR
LTQ@LTP
100@54.39
ATP
54.12
Var Margin
100 %
Circuit Range
49.21-54.39
Delivery %
0 %
Value
2.06 L
ASM/GSM
No
Market Lot
1
About Aspira Pathlab & Diagnostics
NSE : 0
BSE : 540788
ISIN : INE500C01017
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Dr. Haseeb Drabu | Chairman & Ind.Director |
| Dr. Pankaj J Shah | Managing Director & CEO |
| Mr. Nikunj Mange | Executive Director |
| Mr. Manas Mengar | Independent Director |
| Mr. Avinash C Mahajan | Independent Director |
Aspira Pathlab & Diagnostics Similar Stocks
Vista Pharmaceuticals Ltd.
10.65
-0.45 (4.05%)
Shelter Pharma Ltd.
41.10
-2.38 (5.47%)
Vivo Bio Tech Ltd.
38.00
-0.70 (1.81%)
Medicamen Organics Ltd.
NaN
0.00 (0.00%)
NG Industries Ltd.
160.05
-8.85 (5.24%)
Vineet Laboratories Ltd.
NaN
-31.46 (3146.00%)
Sandu Pharmaceuticals Ltd.
53.00
-0.05 (0.09%)
Centenial Surgical Suture Ltd.
138.65
-0.05 (0.04%)
Amkay Products Ltd.
43.60
-1.40 (3.11%)
Chandra Bhagat Pharma Ltd.
56.00
0.00 (0.00%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 54.39 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 27.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 0. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 48.64 & 4.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 53.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 106.78 & 25.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.